Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05BMC
|
||||
Former ID |
DIB013064
|
||||
Drug Name |
GW-42004
|
||||
Synonyms |
CB1/CB2 receptor antagonist (oral/capsule, obesity/type 2 diabetes/dyslipidemia), GW Pharmaceuticals
|
||||
Indication | Lipid metabolism disorder [ICD10:E75-E78] | Phase 2 | [549419] | ||
Company |
GW Pharmaceuticals plc
|
||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Modulator | ||
Cannabinoid receptor 1 | Target Info | Modulator | |||
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.